Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Ken Cacciatore's Stock Ratings
TD Cowen Analyst
Ken Cacciatore is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/24/2025
Overall Average Return
-30.5%
Smart Score
Overall Average Return Percentile
7th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/09/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $14.25 | 250.79% | Ken Cacciatore26% | $65 → $50 | Maintains | Outperform | Get Alert |
| 06/16/2023 | BHC | Buy Now | Bausch Health Companies | $4.46 | — | Ken Cacciatore26% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/16/2023 | TAK | Buy Now | Takeda Pharmaceutical | $14.57 | 37.27% | Ken Cacciatore26% | $30 → $20 | Maintains | Outperform | Get Alert |
| 05/08/2023 | ISEE | Buy Now | IVERIC bio | — | — | Ken Cacciatore26% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/04/2023 | TAK | Buy Now | Takeda Pharmaceutical | $14.57 | 105.9% | Ken Cacciatore26% | $24 → $30 | Maintains | Outperform | Get Alert |
| 12/01/2022 | SCPH | Buy Now | scPharmaceuticals | $3.50 | 615.25% | Ken Cacciatore26% | → $25 | Initiates | → Outperform | Get Alert |
| 07/19/2022 | TAK | Buy Now | Takeda Pharmaceutical | $14.57 | 64.72% | Ken Cacciatore26% | $21 → $24 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/11/2022 | BLCO | Buy Now | Bausch & Lomb | $11.29 | 210.01% | Ken Cacciatore26% | → $35 | Initiates | → Outperform | Get Alert |
| 07/13/2021 | MOLN | Buy Now | Molecular Partners | $4.04 | 1137.62% | Ken Cacciatore26% | → $50 | Initiates | → Outperform | Get Alert |
| 02/01/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $14.25 | 461.26% | Ken Cacciatore26% | $55 → $80 | Maintains | Outperform | Get Alert |
| 10/19/2020 | TARA | Buy Now | Protara Therapeutics | $3.16 | 1482.28% | Ken Cacciatore26% | → $50 | Initiates | → Outperform | Get Alert |
| 04/17/2020 | BHVN | Buy Now | Biohaven | $15.64 | 187.72% | Ken Cacciatore26% | → $45 | Initiates | → Outperform | Get Alert |
| 03/02/2020 | AMRN | Buy Now | Amarin Corp | $11.03 | 108.52% | Ken Cacciatore26% | → $23 | Initiates | → Outperform | Get Alert |
| 01/24/2020 | ISEE | Buy Now | IVERIC bio | — | — | Ken Cacciatore26% | → $15 | Initiates | → Outperform | Get Alert |
| 12/18/2019 | OPTN | Buy Now | OptiNose | $9.65 | 159.07% | Ken Cacciatore26% | → $25 | Initiates | → Outperform | Get Alert |
| 11/01/2019 | TAK | Buy Now | Takeda Pharmaceutical | $14.57 | 33.84% | Ken Cacciatore26% | → $19.5 | Initiates | → Market Perform | Get Alert |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | Ken Cacciatore26% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/15/2014 | VSAR | Buy Now | Versartis, Inc. | — | — | Ken Cacciatore26% | → $45 | Initiates | → Outperform | Get Alert |
